CHANGE IN RATINGS

Altera

(ALTR) - Get Report

upgraded at AG Edwards: ALTR was upgraded from Hold to Buy, AG Edwards said. $24 price target. Accounting problems have been solved, and the stock is trading at 23 times 2008 estimates.

Cooper Inds.

( CBE) upgraded at CIBC: CBE was upgraded from Sector Perform to Outperform, CIBC said. $105 price target. Estimates also raised, as the company is realizing productivity gains.

E*Trade

(ET) - Get Report

rated new Neutral at Credit Suisse: Credit Suisse said it is initiating coverage on ET with a Neutral rating. Cites stock remains ahead of peers in migrating to more integrated financial services. Sets $26 target price.

Hubbell

(HUBB) - Get Report

downgraded at CIBC: HUB.B was downgraded from Outperform to Sector Perform, CIBC said. $55 price target. Stock is at the high end of its recent trading range, and some downside potential exists to near-term earnings.

MBIA

(MBI) - Get Report

downgraded at Citigroup: MBI was downgraded from Buy to Hold, Citigroup said. $73 price target. Stock should benefit from likely Eurotunnel resolution this month.

MetLife

(MET) - Get Report

downgraded at Friedman, Billings: MET was downgraded from Market Perform to Underperform, Friedman, Billings Ramsey said. Spreads continue to shrink and now fees are dropping as well.

Pfizer

(PFE) - Get Report

downgraded at Merrill: PFE was downgraded from Buy to Neutral, Merrill Lynch said. Company may never be able to replace Lipitor. Valuation and yield could lend support to the shares.

Pfizer

(PFE) - Get Report

downgraded at JP Morgan: PFE was downgraded from Overweight to Neutral, JP Morgan said. Failure of the cholesterol drug will have both a financial and strategic impact on the company.

Principal Financial

(PFG) - Get Report

upgraded at Wachovia: PFG was upgraded from Underperform to Market Perform, Wachovia said. Market is already pricing in earnings drag from the capital-driven business.

Charles Schwab

(SCHW) - Get Report

rated new Buy at Credit Suisse:Credit Suisse said it is initiating coverage on SCHW with an Outperform rating. Believes transformation is complete following restructuring efforts. Sees company as an asset gathering machine. Sets $24 target price.

STOCK COMMENTS / EPS CHANGES

Amgen

(AMGN) - Get Report

estimates, price target cut at Morgan Stanley: Morgan Stanley believes threats to Amgen's EPO franchise continue to grow, and a contraction of Epogen is almost inevitable. Morgan Stanley cuts 2008 EPS estimates and lowers price target to $71.

Continental

(CAL) - Get Report

numbers cut at Morgan Stanley: Morgan Stanley cuts Continental Airlines Q4 EPS estimates after the company reported weaker than expected November RASM of only 2-3%.

Isle of Capri

(ISLE)

price target raised at Jefferies: ISLE price target raised, said Jefferies. New target goes to $34.00 from $33.00. Reiterated Buy rating.

Merck

(MRK) - Get Report

estimates raised at Goldman Sachs: Goldman said it is increasing its 2007 estimates on MRK to $2.50 from $2.45 following the results of a pediatrician survey regarding HPV vaccines. Results showed strength in Merck's Gardasil. Maintained Sell rating and $36 target.

Office Depot

(ODP) - Get Report

price target cut at Goldman Sachs: Goldman said that it is lowering its target on ODP to $44 from $47 due to weak domestic sales trends in the fourth quarter. Maintained Neutral rating.

STRATEGY CALLS / MARKET CALLS

Two Trucking stocks downgraded at Merrill:Merrill Lynch said it downgraded CNW and ABFS to Sell, citing a considerable drop in LTL volumes. Price competition is also increasing, which leads to forward estimate cuts.